More about
Atezolizumab
News
July 21, 2020
1 min read
Save
Triple therapy has comparable results in relapsed/refractory B-cell lymphoma
News
July 14, 2020
4 min read
Save
Atezolizumab plus chemotherapy improves PFS in metastatic urothelial carcinoma
News
July 01, 2020
4 min read
Save
Growing treatment landscape in SCLC spurs excitement
News
June 25, 2020
4 min read
Save
FDA approves four NSCLC regimens
News
June 19, 2020
1 min watch
Save
VIDEO: Tiragolumab plus atezolizumab confers benefit for certain patients with NSCLC
News
June 18, 2020
1 min read
Save
Atezolizumab regimen improves outcomes in early triple-negative breast cancer
News
June 15, 2020
3 min watch
Save
VIDEO: Novel immune targets in lung cancer ‘generate excitement’
News
June 02, 2020
2 min read
Save
FDA approves immunotherapy regimen for advanced liver cancer
News
June 01, 2020
4 min read
Save
Adjuvant atezolizumab fails to extend DFS in high-risk urothelial carcinoma
News
May 22, 2020
5 min read
Save
Immunotherapy or TKI: Debating the best HCC treatment options

Thomas A. Abrams, MD, senior physician at Dana-Farber Cancer Institute and assistant professor of medicine at Harvard Medical School, spoke with Healio about treatment options for patients with hepatocellular carcinoma. He discusses first-line treatment, guidance on aspirin use and important, recent FDA approvals.